美鼎生物(VIVO)

莫芒旎2022-08-14 09:00

$美鼎生物(VIVO)$ 收购什么时候完成？瞎买了230120的35看涨期权，是不是打水漂了？查看全文

用户28964502982022-07-08 16:40

$美鼎生物(VIVO)$ $美鼎生物(VIVO)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-22-189072查看全文

牛唐2022-07-08 15:08

韩国SD Biosensor和SJL Partners (Consortium)以15.3亿美元全现金收购$美鼎生物(VIVO)$ 。
$东方生物(SH688298)$ $金域医学(SH603882)$查看全文

$Meridian Bioscience Inc.(VIVO)$ DEF 14A - Other definitive proxy statements Filed: 2018-12-13 AccNo: 0001193125-18-348327 Size: 644 KB 网页链接

$Meridian Bioscience Inc.(VIVO)$ 8-K - Current report Filed: 2018-12-12 AccNo: 0000892251-18-000086 Size: 102 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 9.0...

$Meridian Bioscience Inc.(VIVO)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2018-11-29 AccNo: 0001193125-18-337257 Size: 5 MB 网页链接

$Meridian Bioscience Inc.(VIVO)$ 内部交易: 2018-11-20,Director,Rice John McCune Jr. ,期权,2000普通股, $13.55

$Meridian Bioscience Inc.(VIVO)$ 内部交易: 2018-11-13,EVP, Global Operations,BALDINI LAWRENCE ,卖出,9876普通股, $19.55

$Meridian Bioscience Inc.(VIVO)$ 内部交易: 2018-11-12,EVP, Global Operations,BALDINI LAWRENCE ,卖出,25225普通股, $19.35

$Meridian Bioscience Inc.(VIVO)$ 美东时间 2018-11-16 分红: 0.125 网页链接

$Meridian Bioscience Inc.(VIVO)$ 8-K - Current report Filed: 2018-11-08 AccNo: 0001193125-18-321924 Size: 6 MBItem 2.02: Results of Operations and Financial ConditionItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接

$Meridian Bioscience Inc.(VIVO)$ 内部交易: 2018-11-05,Director,McIlwraith John ,期权,2000普通股, $12.80

$Meridian Bioscience Inc.(VIVO)$ 8-K - Current report Filed: 2018-11-01 AccNo: 0000892251-18-000078 Size: 15 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接